Variant report
Variant | esv3398743 |
---|---|
Chromosome Location | chr4:54072895-54074843 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549377642 | chr4:54072906-54072907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577375152 | chr4:54072933-54072934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4515222 | chr4:54072951-54072952 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs140125458 | chr4:54073014-54073015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538132570 | chr4:54073066-54073067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145119430 | chr4:54073101-54073102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544260003 | chr4:54073148-54073149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560846631 | chr4:54073184-54073185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186710507 | chr4:54073196-54073197 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546569161 | chr4:54073203-54073204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147600429 | chr4:54073221-54073222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532213873 | chr4:54073232-54073233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12640471 | chr4:54073307-54073308 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs142064997 | chr4:54073329-54073330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4529116 | chr4:54073365-54073366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537925877 | chr4:54073369-54073370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554586958 | chr4:54073392-54073393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568102147 | chr4:54073393-54073394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534155894 | chr4:54073431-54073432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77334063 | chr4:54073478-54073479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77506189 | chr4:54073493-54073494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577719590 | chr4:54073498-54073499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554173084 | chr4:54073571-54073572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577437970 | chr4:54073626-54073627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377125829 | chr4:54073640-54073641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150341843 | chr4:54073642-54073643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111241155 | chr4:54073652-54073653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368572387 | chr4:54073671-54073672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556781280 | chr4:54073672-54073673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371547914 | chr4:54073675-54073676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367622903 | chr4:54073680-54073681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs28715261 | chr4:54073683-54073684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs28756025 | chr4:54073684-54073685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372163106 | chr4:54073694-54073695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375151293 | chr4:54073697-54073698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs28363782 | chr4:54073705-54073706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374159308 | chr4:54073715-54073716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368667892 | chr4:54073716-54073717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372348484 | chr4:54073727-54073728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368479956 | chr4:54073735-54073736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377290315 | chr4:54073737-54073738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs369840213 | chr4:54073738-54073739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374360286 | chr4:54073741-54073742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545512134 | chr4:54073742-54073743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368879500 | chr4:54073766-54073767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373358784 | chr4:54073768-54073769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372556653 | chr4:54073786-54073787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs115950313 | chr4:54073869-54073870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4529117 | chr4:54073905-54073906 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs28661921 | chr4:54073953-54073954 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Glioblastoma | 17504929 | CNVD |
Glioblastoma | 16823502 | CNVD |
Melanoma | 16908931 | CNVD |
Glioblastoma | 20031968 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Gastrointestinal stromal cancer | 17438095 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Wilms tumour | 21544195 | CNVD |
Cancer | 20164919 | CNVD |
Gastrointestinal stromal cancer | 17527083 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17209131 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:54043200-54077000 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr4:54048000-54086000 | Weak transcription | GM12878-XiMat | blood |
3 | chr4:54051000-54073000 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
4 | chr4:54053000-54093000 | Weak transcription | Primary B cells from cord blood | blood |
5 | chr4:54056600-54076400 | Weak transcription | Ovary | ovary |
6 | chr4:54058200-54079800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
7 | chr4:54063400-54079400 | Weak transcription | Primary hematopoietic stem cells | blood |
8 | chr4:54064400-54078400 | Weak transcription | Small Intestine | intestine |
9 | chr4:54064400-54106600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr4:54066200-54080000 | Weak transcription | Psoas Muscle | Psoas |
11 | chr4:54066400-54099000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr4:54069800-54074600 | Weak transcription | HepG2 | liver |
13 | chr4:54070000-54074800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr4:54072200-54073000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr4:54072600-54085000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
16 | chr4:54072800-54089000 | Weak transcription | NHDF-Ad | bronchial |
17 | chr4:54073000-54073400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
18 | chr4:54073400-54077000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
19 | chr4:54073400-54079200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
20 | chr4:54074400-54075600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr4:54074600-54075400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
22 | chr4:54074600-54075600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
23 | chr4:54074600-54075600 | Enhancers | HepG2 | liver |
24 | chr4:54074800-54075400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
25 | chr4:54074800-54075600 | Enhancers | HUES64 Cell Line | embryonic stem cell |